Overview The Evaluation of Bioequivalence Between a Single-dose Pen and a Multi-dose Pen of HRS9531 Injection Solution Status: COMPLETED Trial end date: 2025-06-06 Target enrollment: Participant gender: Summary The study is being conducted to evaluate the bioequivalence between a single-dose pen and a multi-dose pen of HRS9531 injection solution.Phase: PHASE1 Details Lead Sponsor: Fujian Shengdi Pharmaceutical Co., Ltd.